Aska Pharmaceutical Company Limited

A previous regulatory setback in the US for Kissei Pharmaceutical Co., Ltd ’s female health product linzagolix has not discouraged the Japanese firm from continued development of the oral gonadotropi

The Japanese government and associations of domestic firms are trying to improve quality control and bring back stable distribution to the generics sector. While the country has almost reached its vol

Japan's national health insurance (NHI) system will include infertility treatments in its reimbursement coverage from 1 April 2022, in a policy move set to transform access and which looks set to lead

JCR Pharmaceuticals Co., Ltd. has received the first approval worldwide, in Japan, for Izcargo (pabinafusp alfa), its novel therapy for mucopolysaccharidosis type II (MPS II, or Hunter syndrome). The